Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Koch

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nanomedicine (London, England)|August 25, 2007
Insulin: a model system for nanomedicine?Manuela Koch, Franziska F-F Schmid, Vincent Zoete, et al.
International Journal of Women'S Health|April 24, 2013
EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessationKonstanze Diefenbach, Dietmar Trummer, Frank Ebert, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitutionDaniël M Jonker, Manuela Koch, Per Larsson, et al.
Human Reproduction (Oxford, England)|June 12, 2016
Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy womenBarbara Schütt, Andreas Kaiser, Marcus-Hillert Schultze-Mosgau, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjectsNassr Nassr, Andreas Huennemeyer, Rolf Herzog, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nanomedicine (London, England)|August 25, 2007
Insulin: a model system for nanomedicine?Manuela Koch, Franziska F-F Schmid, Vincent Zoete, et al.
International Journal of Women'S Health|April 24, 2013
EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessationKonstanze Diefenbach, Dietmar Trummer, Frank Ebert, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 8, 2021
First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitutionDaniël M Jonker, Manuela Koch, Per Larsson, et al.
Human Reproduction (Oxford, England)|June 12, 2016
Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy womenBarbara Schütt, Andreas Kaiser, Marcus-Hillert Schultze-Mosgau, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjectsNassr Nassr, Andreas Huennemeyer, Rolf Herzog, et al.
Pageof 1